NoduleRisk vs PE
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
NoduleRisk
Read full descriptionHide full description
NoduleRisk is a clinical decision support tool for physicians evaluating pulmonary nodule malignancy risk. It computes probability estimates and management guidance across five validated models simultaneously. MODELS INCLUDED • Mayo Clinic (ACCP) — logistic regression model for incidentally detected nodules • Brock (BTS/PanCan) — recommended for screening populations; validated in the Pan-Canadian Lung Cancer Screening Study • Herder (BTS) — incorporates FDG-PET/CT uptake when available • BIMC (Bayesian) — Bayesian likelihood ratio model with adjustable prior probability; displays individual likelihood ratio contributions • Fleischner 2017 — guideline-based follow-up recommendations with automatic risk stratification FEATURES • Multi-nodule evaluation (up to 6 nodules per patient) • Volume doubling time calculation from serial CT measurements • Risk-stratified management recommendations for each model • Applicability warnings when inputs are outside model validation ranges • Clinical context adjustments for screening and biopsy-referred populations • Fully offline — no data is transmitted or stored IMPORTANT NoduleRisk is intended for use by qualified clinicians as a decision support aid only. Results must be interpreted in the context of the full clinical picture and do not substitute for institutional guidelines, multidisciplinary team discussion, or clinical judgment.
PE
Read full descriptionHide full description
2026 AHA/ACC guidelines for the evaluation and management of acute pulmonary embolism in adults. Tabbing the guideline citation opens the AHA/ACC publication in Safari for reference
Screenshots
Verdict
The clearest difference is iOS requirement: NoduleRisk at 17.6 against PE's 26.4. On price, ads, in-app purchases and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
| Parameter | NoduleRisk | PE |
|---|---|---|
| Price | Free | Free |
| Ads | No | No |
| In-app purchases | No | No |
| Devices | iPhone | iPhone, iPad — better |
| Requires iOS | 17.6 — better | 26.4 |
| Further details — not scored | ||
| Size | 2 MB | 2 MB |
| Age rating | 17+ | 4+ |
| Developer | Rutvik Shah | Ryan Mitchell |
In-app purchases
NoduleRisk
No in-app purchases
PE
No in-app purchases









